The authors of PLoS Biology Bubela et al. guess avoid the conditions of reach through on both sides. Such clauses are problematic not only with regard to intellectual property policy, but also from a negotiating point of view. Indeed, they have probably delayed or even prevented a final agreement. It is therefore almost impossible to impose reach-through conditions, which is why they are of limited use, the authors note, and write literally: “A policy against reach-through should apply for all MTAs – research institutions should be very wary of such terms that commonly attach to research materials shared by industry.” 3. Please send an email in advance with the full order form (Annex) by clicking “SEND” at the end of the last page or as a PDF file directly to material-transfer[helmholtz-muenchen.de]. This speeds up the release of the requested material once the SMTA is signed by mail. If you are planning to send or receive materials from other laboratories, research centers or companies, this should be formalized with a Material Transfer Agreement (MTA). For simple transfers not involving intellectual property, the NIH recommends a Simple Letter Agreement. For materials that may be patented or for which more protection is desired, the Uniform Biological Material Transfer Agreement (UBMTA) can be used.
Many U.S. educational institutions have signed the UBMTA Master Agreement.  AUTM (previously the Association of University Technology Managers) serves as the repository for the original UBMTA Master Agreements and maintains the list of the signatories.  Signatories to the UBMTA only have to sign an Implementing Letter with the details of the particular transfer since they have already agreed to all the terms of the Master Agreement. “For the most commonly used MTAs, there are in particular two restrictions on material transfer, which are often neither useful nor desired,” Kahl explains. First, the transferred materials would not normally be shared with third parties. Second, any commercial use is expressly prohibited. The latter is stated by UBMTA as follows: “If the Recipient desires to use or license the Material or Modifications for commercial purposes, the Recipient agrees, in advance of such use, to negotiate in good faith with the Provider to establish the terms of a commercial license.” This does not necessarily preclu her commercial use. Herzog explains: “If we want to use commercially a material that we received with a UBMTA, we need to talk to the supplier.” Legal service at: